Editorial: Immunology and immunopathogenesis of human leishmaniasis

Editorial: Immunology and immunopathogenesis of human leishmaniasis

Bibliographic Details
Main Authors:	Juliana P. B. de Menezes, Cláudia Brodskyn, Ricardo Gonçalves, Olivia Bacellar
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	human leishmaniasis immunopathogenesis IL-32 IL-17 peroxisome proliferator-activated receptor-γ (PPAR-γ) pioglitazone
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.1055221/full

Similar Items

Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes
by: Maurício T. Nascimento, et al.
Published: (2022-07-01)

Synergistic effects of PI3K inhibition and pioglitazone against acute promyelocytic leukemia cells
by: Shadi Esmaeili, et al.
Published: (2023-03-01)

Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches
by: M S Rasin
Published: (2013-09-01)

Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 gene on lipid profile and adipokines levels in obese subjects
by: Becer E, et al.
Published: (2017-06-01)

Dexmedetomidine ameliorates hyperalgesia of rat models with neuropathic pain via upregulation of PPAR-γ
by: ZHU Feng, ZHONG Yue, DENG Yijiang, LIU Wenzhi, BIAN Jiang
Published: (2023-09-01)

Enhancement of cognitive functions by rice bran extract in a neuroinflammatory mouse model via regulation of PPARγ
by: A.O. Mostafa, et al.
Published: (2018-09-01)

Peroxisome proliferator-activated receptor-γ as the gatekeeper of tight junction in Clostridioides difficile infection
by: Yi-Hsin Lai, et al.
Published: (2022-11-01)

Reno-protective effect of mangiferin against methotrexate-induced kidney damage in male rats: PPARγ-mediated antioxidant activity
by: Seba Hassan Attia, et al.
Published: (2022-09-01)

Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models
by: Huilan Zeng, et al.
Published: (2022-02-01)

Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs
by: Xiaojing Zhang, et al.
Published: (2022-12-01)

Inverse Relationship between 15-Lipoxygenase-2 and PPAR-γ Gene Expression in Normal Epithelia Compared with Tumor Epithelia
by: Vemparala Subbarayan, et al.
Published: (2005-03-01)

Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats
by: Li Sun, et al.
Published: (2017-08-01)

Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)
by: Manjunath Krishnappa, et al.
Published: (2020-06-01)

Effects of peroxisome proliferator activated receptor gamma (PPARγ) agonist on fasting model applied neuron cultures
by: Pınarbaşı Arzu, et al.
Published: (2021-10-01)

Structural basis of the activation of PPARγ by the plasticizer metabolites MEHP and MINCH
by: Abibe Useini, et al.
Published: (2023-03-01)

Transdifferentiation of bovine epithelial cells towards adipocytes in the presence of myoepithelium
by: Subi Sugathan, et al.
Published: (2020-02-01)

Di-(2-ethylhexyl) phthalate substitutes accelerate human adipogenesis through PPARγ activation and cause oxidative stress and impaired metabolic homeostasis in mature adipocytes
by: Alexandra Schaffert, et al.
Published: (2022-06-01)

Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-fat diet via PPAR-γ activation
by: Wei-Hsuan Hsu, et al.
Published: (2013-01-01)

Pioglitazone in spontaneous subarachnoid hemorrhage: study protocol of a multicenter, double-blind, randomized trial (PSSH)
by: Junhui Chen, et al.
Published: (2024-01-01)

Pioglitazone Alleviates Cardiac Fibrosis and Inhibits Endothelial to Mesenchymal Transition Induced by Pressure Overload
by: Wen-Ying Wei, et al.
Published: (2017-12-01)

Effect of pioglitazone treatment in a patient with secondary multiple sclerosis
by: Pershadsingh Harrihar A, et al.
Published: (2004-04-01)

Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway
by: Wenlin Chen, et al.
Published: (2018-08-01)

<i>Pparγ1</i> Facilitates ErbB2-Mammary Adenocarcinoma in Mice
by: Xuanmao Jiao, et al.
Published: (2021-04-01)

PPAR𝛾 gene and atherosclerosis: Genetic polymorphisms, epigenetics and therapeutic implications
by: Grbić E, et al.
Published: (2018-10-01)

Assessment of intralesional cytokine profile of cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka
by: Lahiru Sandaruwan Galgamuwa, et al.
Published: (2019-01-01)

Down-regulation of miR-27a alleviates lung injury in septic rat models
by: LI Jia-jin, LIU Jun, HE Song-yu, CHEN Hao-yun
Published: (2022-11-01)

Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation
by: Alexandra Schaffert, et al.
Published: (2021-11-01)

The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells
by: Carmen Ciavarella, et al.
Published: (2023-02-01)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
by: Gray Elizabeth, et al.
Published: (2012-04-01)

Overt Acute Hepatitis B Deteriorates in Females: Destructive Immunity With an Exaggerated Interleukin-17 Pathway
by: Ming-Ling Chang, et al.
Published: (2021-11-01)

PPARγ activation improved learning and memory and attenuated oxidative stress in the hippocampus and cortex of aged rats
by: Farimah Beheshti, et al.
Published: (2022-12-01)

NRF2 and PPAR-γ Pathways in Oligodendrocyte Progenitors: Focus on ROS Protection, Mitochondrial Biogenesis and Promotion of Cell Differentiation
by: Chiara De Nuccio, et al.
Published: (2020-09-01)

A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist
by: Federica Papaccio, et al.
Published: (2022-11-01)

Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats
by: Szu-Yu Liu, et al.
Published: (2021-11-01)

Corrigendum: Peroxisome proliferator–activated receptor-α: A pivotal regulator of the gastrointestinal tract
by: Yue-Xin Guo, et al.
Published: (2022-10-01)

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease
by: Yongyan Song, et al.
Published: (2022-03-01)

Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway
by: Huixia Lu, et al.
Published: (2017-11-01)

Enhanced 3T3-L1 Differentiation into Adipocytes by Pioglitazone Pharmacological Activation of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ)
by: Catarina Teixeira, et al.
Published: (2022-05-01)

The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies
by: Giuseppina Augimeri, et al.
Published: (2020-09-01)

Clinical and immunological study of specific Mycobacterium bovis-BCG transfer factor in lambs
by: Elaf A. Nayyef, et al.
Published: (2021-12-01)